Difficulty: Medium
Average Score: 64%
Practice
A 42-year-old man with ALS presents to his primary care physician for follow-up. He has not had any issues in the last few years and does not need supplemental oxygen. Which of the following agents may be beneficial to delay the need for ventilator support in this patient?
Correct answer
C
Rationale
Riluzole is the only FDA-approved drug for ALS that has been shown to slow disease progression and delay the need for ventilator support.